Change currency
Orphan Drug Markets in Europe (URC00044)
Key developments and the strategies of major pharmaceutical companiesThe first marketing authorisations for orphan drugs in Europe took place a decade ago. Since then there have been over 60 designated orphan products. These products now account for annual...
Nov 2011£1,495€1,774$2,408
Healthcare and Pharmaceuticals in Latin America (URC00010)
A guide to the markets and regulationsLatin America continues to be a region of promising opportunities for commercial pharmaceutical organisations. The region represents a growing consumer base for the drug industry as by 2020 the regional...
Sep 2011£995€1,181$1,603
Pharmaceutical Market Trends, 2010 - 2014 (URC00032)
Key market forecasts & growth opportunities (4th Edition)Pharmaceutical Market Trends, 2010 - 2014: Key market forecasts & growth opportunities presents a detailed trend analysis of the global pharmaceutical market to the end of 2009 and forecasts until 2014. This 142 page...
Oct 2010£1,495€1,774$2,408
Future of European Pharmaceutical Distribution, The (URC00035)
The impact of DTP on manufacturers and wholesalersReducing the number of wholesalers helps to reduce internal costs for manufacturers, and by dealing only with a few wholesalers may create more manageable business relationships The European pharmaceutical distribution system...
Jul 2010£1,895€2,248$3,053
Biosimilars: A Growing Market (URC00033)
An overview of developments, companies & commercial opportunitiesAlthough a number of major companies have significant biological capabilities, few apart from Novartis have yet clearly developed strategies to compete in the biosimilars market Since Sandoz pioneered the development of...
Mar 2010£1,495€1,774$2,408
World Market for Addiction Disorders, 2009-2016 (URC00031)
The Future Therapies for Substance Dependence and Impulse ControlA comprehensive update of the 2005 edition Examines the market for addiction pharmacotherapies currently estimated at US$2 billion The substance dependence field is transforming into a high-growth market opportunity. Supported by the...
Oct 2009£1,495€1,774$2,408
Pharmaceutical Distribution in the US (URC00030)
Current and Future PerspectivesIn recent years, the US government and interested parties have made increasing efforts to protect the national supply chain for medicines distribution. Since it represents the means for medicines to...
Jun 2009£1,495€1,774$2,408
Generic Competition, 2009 to 2013 (URC00019)
The impact of patent expiries on sales of major drugsThe period 2009–13 will see major companies facing very different degrees of exposure to the potential loss of revenue to generics. Eli Lilly, Pfizer, Bristol-Myers Squibb, Merck and Takeda all face the potential loss...
Apr 2009£995€1,181$1,603
Mergers and Aquisitions in the Pharmaceuticals Sector, 2009 (URC00029)
Critical success factors for competing in a consolidating market"2009 is set to redefine the structure and dynamics of the pharmaceutical industry in a way not seen since the year 2000" Background On 26th January 2009, Pfizer announced plans to acquire...
Apr 2009£995€1,181$1,603
How to Forecast Generic Pharmaceutical Prices (URC00028)
A practical methodology to calculate future generic product prices How to Forecast Generic Pharmaceutical Prices - A practical method to estimate future generic product prices is a unique guide that will help you be able to forecast future generic...
Mar 2009£2,500€2,966$4,027
Major Pharmaceutical Markets of the Middle East (URC00016)
An overview of Egypt, Israel, Jordan, Lebanon, Saudi Arabia & UAE (2nd Ed)Fully updated version of this best-selling, comprehensive report which provides extensive coverage of one the strongest emerging pharmaceutical market regions. "Massive growth is being forecast for the pharmaceutical and biotechnology...
Feb 2009£1,295€1,536$2,086
Cancer Market Trends 2008 - 2012 (URC00018)
The global cancer market has seen a continued period of rapid growth. Global sales for cancer-treating drugs increased by 13.3% in 2007, primarily driven by growth in sales of innovative...
Jan 2009£1,100€1,305$1,772
Drug Registration in China (URC00027)
A comprehensive overview of proceduresThe revised Drug Registration Procedure was introduced on 10 July 2007, coming into effect on 1 October 2007, at which point some changes were made to the current practice, as...
Sep 2008£495€587$797
Manufacturing in the Global Pharmaceuticals Industry (URC00003)
Key drivers, company strategies and regulations (3rd Edition)The new edition of this best-selling report offers insight into the manufacturing process, strategy, issues and drivers from an expert author. Manufacturing in the Global Pharmaceuticals Industry - Key drivers, company...
Sep 2008£899€1,067$1,448
Pharmaceutical Distribution in Europe (URC00025)
The Emergence of Direct-to-Pharmacy Supply"Each day millions of patients across Europe rely on the supply chain to deliver the medicines they need" Pharmaceutical Distribution in Europe - The Emergence of Direct-to-Pharmacy Supply from URCH...
Feb 2008£995€1,181$1,603
Pharmaceutical Product Approval Trends, 2007 (URC00024)
Key Market Benchmarks And Strategic Insights "Among The 23 New Pharmaceutical Products Approved In The First Half Of 2007, There Were 22 Small Molecule Pharmaceutical Drugs And One Monoclonal Antibody." Pharmaceutical Product Approval Trends 2007: Key Market...
Dec 2007£1,299€1,541$2,092
Consolidation in the Generic Pharmaceutical Industry (URC00023)
An Evolving LandscapeFor many years generic companies were the poor relations of the pharmaceutical industry, with modest growth rates and little or no transnational business operations. As generics companies have grown, often...
Oct 2007£1,250€1,483$2,014
Cardiovascular Pharmaceutical Market Trends, 2007 to 2010 (URC00021)
Key market forecasts and growth opportunitiesThe global cardiovascular market grew to US$89.7 billion in 2005, a year-on-year increase of 9.6%. The global cardiovascular market is forecast to expand to US$116.3 billion in 2010, equivalent to a...
Aug 2007£895€1,062$1,442
CNS Market Trends, 2007 to 2010 (URC00020)
Key Market Forecasts and Growth OpportunitiesThe global market for drugs treating Central Nervous System (CNS) disorders has grown rapidly in recent years to reach US$55.5 billion in 2005, a year-on-year increase of 6.6%. Between 2003 and...
Jun 2007£995€1,181$1,603
Preparing Health Technology Submissions for Pharmaceutical Products (URC00015)
Meeting Formulary Submission Requirements for New Product Assessments and Disease Area & Therapeutic Class ReviewsPreparing health technology submissions for pharmaceutical products - Meeting Formulary Submission Requirements for New Product Assessments and Disease Area and Therapeutic Class Reviews, considers how manufacturers should respond to emerging...
Apr 2006£1,550€1,839$2,497
The Global BioGenerics Market in 2010 (URC00014)
A Consensus Market Models reportBioGenerics is an umbrella term used to define the market for bioequivalent products based on the same biological substance used in off-patent biologics. The BioGeneric market is set to develop...
Nov 2005£495€587$797
Guide to Pharma Pricing & Reimbursement Systems (URC00013)
Western EuropeNational pharmaceutical pricing and reimbursement is a complex and ever-changing area. In a rapidly globalising market it is essential that executives are briefed on the regulatory systems that determine the...
Nov 2005£299€355$482
Pricing & Reimbursement of Medicines in the United Kingdom (URC00011)
Understanding the pharmaceutical market in the healthcare systemNational pharmaceutical pricing and reimbursement is a complex and ever-changing area. In a rapidly evolving market it is essential that executives are briefed on the regulatory systems that determine the...
Jun 2005£450€534$725
Orphan Drugs to 2008 (URC00009)
Understanding regulation & market opportunity in EuropeOrphan Drugs to 2008- Understanding regulation & market opportunity in Europe is designed for executives to understand the market environment for orphan drugs. The content will help all global companies...
Jan 2005£995€1,181$1,603
Pharmaceutical Pricing (URC00008)
Global perspectivesPharmaceutical Pricing - Global Perspectives is a strategic report, that analyses all aspects of pharmaceutical pricing and reimbursement strategies through extensive use of case studies. The pricing of new pharmaceutical...
Sep 2004£625€742$1,007